We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 81-100 of 10,000 results
  1. Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson’s disease

    Objectives

    Iron deposition and mitochondrial dysfunction are closely associated with the genesis and progression of Parkinson’s disease (PD). This...

    Su Yan, Jun Lu, ... Yi Wang in European Radiology
    Article 19 October 2023
  2. Transcranial alternating current stimulation improves quality of life in Parkinson’s disease: study protocol for a randomized, double-blind, controlled trial

    Background

    The neural cells in the brains of patients with Parkinson’s disease (PWP) display aberrant synchronized oscillatory activity within the...

    Hong-yu Zhang, Ting-ting Hou, ... Bo-yan Fang in Trials
    Article Open access 20 March 2024
  3. Application of single wrist-wearable accelerometry for objective motor diary assessment in fluctuating Parkinson’s disease

    Advanced Parkinson’s disease (PD) is characterized by motor fluctuations including unpredictable oscillations remarkably impairing quality of life....

    Matthias Löhle, Jonathan Timpka, ... Alexander Storch in npj Digital Medicine
    Article Open access 17 October 2023
  4. Cerebellar and cerebral white matter changes in Parkinson’s disease with resting tremor

    Purpose

    Cerebellum modulates the amplitude of resting tremor in Parkinson’s disease (PD) via cerebello-thalamo-cortical (CTC) circuit. Tremor-related...

    Yuke Zhong, Hang Liu, ... Lifen Chen in Neuroradiology
    Article 07 August 2023
  5. On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson’s Disease Psychosis

    Parkinson’s disease (PD) is associated with the development of psychosis (PDP), including hallucinations and delusions, in more than half of the...

    Fernando L. Pagan, Paul E. Schulz, ... Gregory M. Pontone in CNS Drugs
    Article Open access 08 April 2024
  6. Radiomics score derived from T1-w/T2-w ratio image can predict motor symptom progression in Parkinson’s disease

    Objectives

    To clarify the association between a radiomics score (Rad-score) derived from T1-weighted signal intensity to T2-weighted signal intensity...

    Takuya Shimozono, Takuro Shiiba, Kazuki Takano in European Radiology
    Article 03 July 2024
  7. A biological characterization of patients with postmenopausal Parkinson’s disease

    Menopause increases the risk for Parkinson’s disease (PD), although the underlying biological mechanisms have not been established in patients. Here,...

    Roberta Bovenzi, Tommaso Schirinzi, ... Mariangela Pierantozzi in Journal of Neurology
    Article 16 March 2024
  8. Evaluation of a co-designed Parkinson’s awareness audio podcast for undergraduate nursing students in Northern Ireland

    Background

    Parkinson’s Disease (PD) is a common neurological condition that often causes stiffness, tremor and slow movement. People living with PD...

    Sophie Crooks, Patrick Stark, ... Gary Mitchell in BMC Nursing
    Article Open access 09 October 2023
  9. Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease

    There is a growing appreciation of the wide range of sleep–wake disturbances that occur frequently in Parkinson’s disease. These are known to be...

    Beatrix Feigl, Simon J. G. Lewis, Oliver Rawashdeh in Journal of Neurology
    Article Open access 09 November 2023
  10. Group-based exercise for Parkinson’s: a qualitative study of participants and partners’ perceptions of an exercise class delivered through a community-university collaboration

    Background

    Community-based exercise programmes (CBEPs) offer a practical and viable approach to providing people with Parkinson’s disease (PwP) the...

    Anna Ferrusola-Pastrana, Christopher L Fullerton, Stephen N Meadows in BMC Geriatrics
    Article Open access 04 June 2024
  11. Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson’s disease

    Background

    During the course of their illness, people with Parkinson’s disease may see changes in their insulin-like growth factor (IGF-1) and serum...

    Yifan Yang, Feng Gao, ... Jiaodan Miao in BMC Neurology
    Article Open access 06 October 2023
  12. Acoustical and Perceptual Analysis of Voice in Individuals with Parkinson’s Disease

    Parkinson’s disease is a neurodegenerative disorder that affects motor efficiency which is also required for voice production. Voice is part of the...

    Article 24 November 2022
  13. Impulse control disorders in Parkinson’s disease: a retrospective analysis of 1824 patients in a 12-year period

    Objective

    This study aims to clinically evaluate the impulse control disorders (ICDs) encountered in treating Parkinson’s disease.

    Method ...
    Aysegul Gunduz, Talha Çiftçi, ... Hülya Apaydın in Neurological Sciences
    Article 15 August 2023
  14. Creative thinking and cognitive estimation in Parkinson’s disease

    Background

    Patients with Parkinson’s disease (PD) have been reported to exhibit unusual bouts of creativity (e.g., painting, writing), in particular...

    Marcus Heldmann, Celia Rinckens, ... Thomas F. Münte in Neurological Research and Practice
    Article Open access 15 February 2024
  15. Body composition, Falls, and Freezing of Gait in Parkinson’s Disease: Gender-Specific Effects

    Background

    Postural instability and gait difficulties (PIGD) are a significant cause of mobility loss and lower quality of life in Parkinson’s disease...

    Chatkaew Pongmala, C. Stonsaovapak, ... N. I. Bohnen in The Journal of Frailty & Aging
    Article 02 April 2024
  16. Autophagy markers, cognitive deficits and depressive symptoms in Parkinson’s disease

    Abstract

    Depressive symptoms are common in Parkinson’s disease (PD). The relationships between autophagy and PD or depression have been documented....

    Yanzhe Li, Hechao Yang, ... Jie Li in Journal of Neural Transmission
    Article 06 October 2023
  17. Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease

    Parkinson’s disease (PD) and Alzheimer’s disease (AD) are neurodegenerative disorders with some overlapping clinical features. Hypomimia (reduced...

    Antonio Cannavacciuolo, Giulia Paparella, ... Matteo Bologna in Journal of Neural Transmission
    Article Open access 07 October 2023
  18. Electrophysiological signatures of anxiety in Parkinson’s disease

    Anxiety is a common non-motor symptom in Parkinson’s disease (PD) occurring in up to 31% of the patients and affecting their quality of life. Despite...

    Sahar Yassine, Sourour Almarouk, ... Mahmoud Hassan in Translational Psychiatry
    Article Open access 27 January 2024
  19. Motor and non-motor outcome in tremor dominant Parkinson’s disease after MR-guided focused ultrasound thalamotomy

    Background and objectives

    Magnetic Resonance-guided Focused Ultrasound (MRgFUS) is an emerging technique for the treatment of severe,...

    Veronika Purrer, Emily Pohl, ... Ullrich Wüllner in Journal of Neurology
    Article Open access 31 May 2024
  20. The prevalence of sarcopenia in Parkinson’s disease and related disorders- a systematic review

    Background

    The prevalence of sarcopenia (reduced skeletal muscle strength and mass), Parkinson’s disease (PD) and Parkinson’s related disorders (PRD)...

    Ashley Hart, Laura Cordova-Rivera, ... Alison J. Yarnall in Neurological Sciences
    Article Open access 18 August 2023
Did you find what you were looking for? Share feedback.